Triveni Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Triveni Bio, Inc. - overview
Established
2019
Location
Waltham, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2019, Triveni Bio, Inc. , a. k. a.
Triveni Bio operates as a biotechnology company that focuses on a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. In October 2024, Triveni Bio, Inc. raised USD 115 million in series B funding led by new investor Goldman Sachs, with participation from other new investors Fidelity Management & Research Company and Deep Track Capital. Returning investors Atlas Venture, Cormorant Asset Management, OrbiMed Advisors, Viking Global Investors, and Invus also participated in the round.
Targeting kallikreins 5 and 7 (KLK5/7) directly affects skin barrier function, inflammation, and itching. The company's flagship antibody program, TRIV-509, offers patients with atopic dermatitis and other barrier diseases a significant and much-needed potential therapy option. The company plans to use the October 2024 funding to expand its therapeutic pipeline for inflammatory and immunological disorders.
Current Investors
Atlas Venture, OrbiMed Advisors, Polaris Partners
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics
Website
www.triveni.bio
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.